These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398 [TBL] [Abstract][Full Text] [Related]
7. Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis. Day RM; Cioce V; Breckenridge D; Castagnino P; Bottaro DP Oncogene; 1999 Jun; 18(22):3399-406. PubMed ID: 10362361 [TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1. Recio JA; Merlino G Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907 [TBL] [Abstract][Full Text] [Related]
9. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation. Nakamura T; Kanda S; Yamamoto K; Kohno T; Maeda K; Matsuyama T; Kanetake H Oncogene; 2001 Nov; 20(52):7610-23. PubMed ID: 11753639 [TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+). Weimar IS; Miranda N; Muller EJ; Hekman A; Kerst JM; de Gast GC; Gerritsen WR Exp Hematol; 1998 Aug; 26(9):885-94. PubMed ID: 9694510 [TBL] [Abstract][Full Text] [Related]
11. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice. Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611 [TBL] [Abstract][Full Text] [Related]
12. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells. Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma. Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318 [TBL] [Abstract][Full Text] [Related]
14. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Halaban R; Rubin JS; Funasaka Y; Cobb M; Boulton T; Faletto D; Rosen E; Chan A; Yoko K; White W Oncogene; 1992 Nov; 7(11):2195-206. PubMed ID: 1331934 [TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414 [TBL] [Abstract][Full Text] [Related]
16. The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor are mediated through the cytoplasmic domain of the c-Met receptor. Komada M; Kitamura N Oncogene; 1993 Sep; 8(9):2381-90. PubMed ID: 7689722 [TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor promotes in vitro scattering and morphogenesis of human cervical carcinoma cells. Wong AS; Leung PC; Auersperg N Gynecol Oncol; 2000 Aug; 78(2):158-65. PubMed ID: 10926796 [TBL] [Abstract][Full Text] [Related]
18. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation. Chen Q; DeFrances MC; Zarnegar R Cell Growth Differ; 1996 Jun; 7(6):821-32. PubMed ID: 8780895 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways. Lee WJ; Wu LF; Chen WK; Wang CJ; Tseng TH Chem Biol Interact; 2006 Mar; 160(2):123-33. PubMed ID: 16458870 [TBL] [Abstract][Full Text] [Related]
20. Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor. Zhu H; Naujokas MA; Park M Cell Growth Differ; 1994 Apr; 5(4):359-66. PubMed ID: 8043510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]